Trials / Completed
CompletedNCT06673147
Effects of Nordic Walking on Prenatal Health
Effects of Nordic Walking on Prenatal Health: A Focus on Gait Kinematics, Musculoskeletal Pain, and Quality of Life. A Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- University of Jazan · Other Government
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This randomized controlled trial (RCT) aimed to evaluate the effects of Nordic walking (NW) on gait kinematics, musculoskeletal pain, and quality of life in pregnant women.
Detailed description
Healthy pregnant women (N=50), aged 20-40 years and between 13 and 28 weeks of gestation, experiencing mild to moderate musculoskeletal pain, will be recruited. Participants will be randomized into either an intervention group (NW training) or a control group receiving standard prenatal care. The intervention group will undergo a 4-week learning phase followed by an 8-week NW program (3 sessions per week, 45 minutes per session), led by a certified instructor. Outcome measures will be assessed at baseline, after 4 weeks, and post-intervention (8 weeks), including spatiotemporal gait parameters (will be assessed using the GAITRite system), musculoskeletal pain (will be measured via Visual Analog Scale, VAS), and quality of life (will be measured using the SF-36 Health Survey).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Prenatal Nordic Walking | Traditional Nordic walking poles will be modified according to International Nordic Walking Federation guidelines, which meant that the elbows were bent at a 90°angle when holding the poles in a vertical position. Nordic Walking will be conducted in two phases consisting of a 4-week learning phase followed by an 8-week main phase of intervention. |
Timeline
- Start date
- 2024-11-05
- Primary completion
- 2025-05-06
- Completion
- 2025-06-29
- First posted
- 2024-11-04
- Last updated
- 2025-07-08
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT06673147. Inclusion in this directory is not an endorsement.